Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Status:
COMPLETED
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
Severe obesity is associated with considerable reduction of wellbeing and life expectancy. People living with severe obesity tend to die 8 to 10 years earlier. Preoperative management of patients living with severe obesity can be challenging and proper weight-loss may help obtain better outcomes and less morbidity. The effectiveness of GLP-1 analogue Liraglutide in preoperative weight-loss was evaluated in the study.
Phase:
PHASE4
Details
Lead Sponsor:
Unidad de Cirugia Bariatrica Hospital Civil Dr. Juan I. Menchaca